Giustarini Daniela, Colella Sante, Dalle-Donne Isabella, Rossi Ranieri
Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy.
Center for Colloid and Surface Science (CSGI), University of Florence, Florence, Italy.
FASEB J. 2025 Jul 15;39(13):e70772. doi: 10.1096/fj.202500677RR.
Homocysteinemia is routinely measured as a biomarker of cardiovascular risk, but its pathogenic role remains controversial because it is unclear whether-and how-interventions to lower homocysteine levels provide real benefit. In the present original study, we analyzed in detail the effects of oxidative stress, thiol-disulfide exchange reactions, and plasma thiol levels on homocysteinemia. We conducted a clinical study in a group of healthy, homogeneous individuals (n = 62) in which the different redox forms of plasma thiols and several biomarkers of oxidative stress were determined. Homocysteine was characterized by the fact that it was almost completely present as mixed protein disulfide (about 80%-85%). A strong inverse correlation was found between total homocysteine and glutathione concentrations, whereas no correlation was found between homocysteine and oxidative stress markers. The observation that oxidative stress does not affect total homocysteine levels in plasma was confirmed by in vitro treatments of human blood with a special device that allows slow delivery of oxidants. Experiments with cultured cells showed that they can release glutathione in large quantities with different kinetics over time. In addition, a strong inverse correlation between GSH and total homocysteine has been demonstrated in the plasma of humans of different ages and in mammalian species. All these data support the hypothesis that GSH, once released from cells, can trigger a series of thiol-disulfide exchange reactions leading to the cleavage of protein-bound homocysteine and the increase of free homocysteine, thus promoting its excretion. It can therefore be concluded that homocysteinemia can be regulated by the release of GSH from cells and that, consequently, total homocysteine in plasma can be considered a biomarker of cardiovascular risk without necessarily having a direct causal role. The specificity of this process must be taken into account when investigating the pathogenetic role of homocysteine.
高同型半胱氨酸血症通常作为心血管风险的生物标志物进行检测,但其致病作用仍存在争议,因为目前尚不清楚降低同型半胱氨酸水平的干预措施是否以及如何能带来实际益处。在本原创研究中,我们详细分析了氧化应激、硫醇 - 二硫键交换反应和血浆硫醇水平对高同型半胱氨酸血症的影响。我们对一组健康、同质的个体(n = 62)进行了临床研究,测定了血浆硫醇的不同氧化还原形式以及几种氧化应激生物标志物。同型半胱氨酸的特点是几乎完全以混合蛋白二硫键的形式存在(约80% - 85%)。研究发现总同型半胱氨酸与谷胱甘肽浓度之间存在强烈的负相关,而同型半胱氨酸与氧化应激标志物之间未发现相关性。通过使用一种允许缓慢输送氧化剂的特殊装置对人体血液进行体外处理,证实了氧化应激不会影响血浆中总同型半胱氨酸水平这一观察结果。细胞培养实验表明,细胞能随时间以不同动力学大量释放谷胱甘肽。此外,在不同年龄的人类血浆以及哺乳动物物种中,均已证明谷胱甘肽与总同型半胱氨酸之间存在强烈的负相关。所有这些数据支持了这样一种假设,即谷胱甘肽一旦从细胞中释放出来,就会引发一系列硫醇 - 二硫键交换反应,导致与蛋白质结合的同型半胱氨酸裂解,游离同型半胱氨酸增加,从而促进其排泄。因此可以得出结论,高同型半胱氨酸血症可通过细胞释放谷胱甘肽来调节,因此血浆中的总同型半胱氨酸可被视为心血管风险的生物标志物,而不一定具有直接因果作用。在研究同型半胱氨酸的致病作用时,必须考虑这一过程的特异性。